tradingkey.logo
tradingkey.logo
Search

Myomo Inc

MYO
Add to Watchlist
1.030USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
39.72MMarket Cap
LossP/E TTM

More Details of Myomo Inc Company

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc Info

Ticker SymbolMYO
Company nameMyomo Inc
IPO dateJun 12, 2017
CEOGudonis (Paul R)
Number of employees184
Security typeOrdinary Share
Fiscal year-endJun 12
Address137 Portland Street
CityBOSTON
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code02114
Phone16179969058
Websitehttps://myomo.com/
Ticker SymbolMYO
IPO dateJun 12, 2017
CEOGudonis (Paul R)

Company Executives of Myomo Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.36M
+7.03%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
462.35K
-4.55%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.36M
+7.03%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
462.35K
-4.55%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Myomo Inc?

The top five shareholders of Myomo Inc are: Mr. Paul R. Gudonis

How many institutions hold shares of Myomo Inc (MYO)?

As of 2026Q1, 185 institutions hold shares of Myomo Inc, with a combined market value of approximately 23.44M, accounting for 63.19% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -5843597.00.

What is the biggest source of revenue for Myomo Inc?

In 2026Q1, the Direct to patient business generated the highest revenue for Myomo Inc, amounting to 7.32M and accounting for 72.56% of total revenue.